Acute Kidney Injury & Renal Drug Clearance
Key Takeaways
KDIGO AKI criteria include a creatinine rise of at least 0.3 mg/dL within 48 hours, at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/h for six hours.
Creatinine-based filtration estimates are less reliable during rapidly changing kidney function.
Renal accumulation of cefepime, baclofen, and active sedative or opioid metabolites can mimic new structural brain injury.
Volume responsiveness does not prove that a fluid bolus is beneficial when pulmonary or cerebral congestion is present.
Interpret Kidney Function in the Neurologic Context
Acute kidney injury (AKI) reduces clearance of water, electrolytes, endogenous solutes, and medications. Its neurologic consequences include encephalopathy, seizures, impaired drug elimination, and difficulty maintaining a prescribed sodium concentration. An unconscious patient cannot report urinary retention, flank pain, thirst, or medication adverse effects, so trends and objective examination are essential.
KDIGO defines AKI by a serum creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline known or presumed within seven days, or urine output below 0.5 mL/kg/h for six hours. Creatinine rises after filtration changes and depends on muscle mass and dilution. A near-normal value does not exclude early AKI, while an elevated value may reflect chronic disease. Compare baseline records, serial measurements, urine output, fluid balance, and the clinical timeline.
Localize the Renal Problem
| Mechanism | Examples | Useful assessment |
|---|---|---|
| Reduced perfusion | Hemorrhage, distributive shock, low cardiac output | Perfusion, ultrasound, hemodynamic response, bleeding or infection source |
| Intrinsic injury | Ischemic or nephrotoxic tubular injury, glomerular disease, interstitial nephritis | Urine sediment, exposures, systemic signs, targeted studies |
| Obstruction | Retention, catheter malfunction, ureteric obstruction | Bladder assessment, catheter inspection, renal imaging when indicated |
Urine sodium and fractional sodium excretion are context-dependent. Diuretics, chronic kidney disease, sepsis, and early tubular injury can complicate interpretation. A low fractional sodium excretion is not proof that more fluid will improve the patient. Urine microscopy may reveal granular casts in tubular injury, but absent casts do not exclude it. Proteinuria, dysmorphic erythrocytes, or cellular casts can direct a different evaluation.
Check simple reversible causes promptly. A blocked urinary catheter can create apparent oliguria; severe retention can cause both AKI and agitation. Do not assume that low urine output after osmotherapy is harmless. Conversely, a large urine volume can coexist with renal dysfunction because solute clearance and water excretion are different functions.
Preserve Perfusion Without Producing Congestion
Treat hemorrhage, infection, cardiac dysfunction, or obstruction. Use hemodynamic information to decide whether a fluid challenge is appropriate; a vasopressor or inotrope may be needed when vascular tone or cardiac function is the limiting problem. Monitor lungs, oxygenation, sodium, and cerebral perfusion during resuscitation. A favorable increase in stroke volume with preload does not guarantee that the benefit outweighs the harm of additional edema.
Review nephrotoxins and contrast exposure, but do not automatically defer a time-sensitive CTA for suspected large-vessel occlusion or another life-threatening vascular diagnosis. Balance the diagnostic benefit and kidney risk with the responsible teams. Avoid unsupported promises that a particular prophylactic drug prevents contrast-associated AKI in all patients.
Loop diuretics can manage fluid overload but do not reverse established renal tissue injury. An increase in urine output after furosemide does not demonstrate recovered filtration. Track the total clinical response rather than using urine volume alone as proof that dialysis is unnecessary.
Drug Clearance and Apparent Neurologic Deterioration
Renal dysfunction can prolong sedation and cause neurotoxicity. Cefepime accumulation may produce encephalopathy, myoclonus, and EEG abnormalities. Baclofen toxicity can cause profound coma. Levetiracetam requires maintenance-dose adjustment; loading decisions in emergencies are a separate question. Midazolam's active metabolites, morphine metabolites, and hydromorphone's neuroexcitatory metabolite can accumulate. Fosphenytoin or phenytoin assessment becomes more difficult because uremia and low albumin alter protein binding; a total level may be misleading, and a measured free level is preferable when available.
Medication dosing during AKI is not a one-time admission calculation. Filtration can worsen or recover rapidly, and continuous renal replacement can remove some drugs substantially. Coordinate with pharmacy regarding loading, maintenance, therapeutic monitoring, and the exact dialysis modality. Also consider augmented renal clearance in selected younger trauma patients, where underexposure to renally eliminated antibiotics or antiseizure drugs can occur despite a normal creatinine.
Uremia Versus Other Causes of Coma
Uremic encephalopathy may include inattention, asterixis, myoclonus, seizures, and diffuse EEG slowing. There is no single BUN threshold that establishes the diagnosis or excludes another emergency. Investigate hypoglycemia, sodium disorders, infection, structural lesions, and medication accumulation. Renal replacement is considered for clinically important uremic complications and other urgent indications, not solely because a fixed creatinine number has been crossed.
A useful vignette is a patient with a stable head CT whose kidney function deteriorates after shock while receiving renally cleared medications. The correct approach includes stopping or adjusting the suspected offending drug, assessing EEG when indicated, and treating renal and systemic problems. Increasing sedation because myoclonus is assumed to be agitation may worsen diagnostic uncertainty.
Source checked October 17, 2026: KDIGO AKI guideline. This published guideline is distinct from proposed updates or consultation drafts.
Creatinine is rising rapidly after shock. Why should a calculated eGFR be interpreted cautiously for drug dosing?
All renally cleared drugs become safe
Urine output guarantees normal filtration
Acute changes eliminate the need for pharmacy review
Creatinine is not at steady state
A stable head CT accompanies new coma, myoclonus, AKI, and ongoing cefepime exposure. What must be considered?
Renal drug accumulation and cefepime neurotoxicity
Only recurrent structural hemorrhage
Normal drug clearance because the initial creatinine was normal
A definitive diagnosis of brain death
Sections you finish are checked off in the contents.